Author Capital Partners ("Author Capital" or "AuthorCap"), a Chicago-based principal investment firm, in partnership with ...
A new standard in wheat immune reactivity testing that adds seven new wheat markers to assess immune responses to ...
Cytespace Africa Laboratories (Cytespace), an MLM Medical Labs company and the only fully CAP-accredited central laboratory in South Africa, has significantly expanded its molecular testing ...
Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers ...
Infectious Disease Diagnostics Market Size To Reach USD 63.26 Billion By 2035, Driven By Rapid Testing Adoption And Molecular ...
This expansion marks a significant milestone in the company's continued national growth, extending EmeritusDX's operational footprint beyond California and Pennsylvania and positioning the ...
In a move aimed at revising and standardising laboratory testing charges for drugs, vaccines, and traditional medicines, the ...
The molecular HPV test, replacing the Pap test, allows early detection of high-risk HPV strains. LEM Lab expands testing, including self-tests, to fight cervical cancer.
Happiest Diagnostics, under Happiest Health, has secured NABL accreditation within two years of its inception, paving the way for growth in molecular, genomic, and preventive diagnostics. This ...
Panakeia publishes landmark clinical validation showing AI can deliver rapid molecular profiling for colorectal cancerLargest real-world, ...
Study Finds on MSN
Blood Test Accurately Detects 81% Of Earliest Lung Cancers By Looking For Molecular Chaos
In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...
Archimed, Astorg, HCAP and Salt Creek Capital are among the PE firms investing in the medical laboratory sector.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results